{"name": "ADVENTRX Pharmaceuticals",
 "permalink": "adventrx-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/adventrx-pharmaceuticals",
 "homepage_url": "http://www.adventrx.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "busdev@adventrx.com",
 "phone_number": "858-552-0866",
 "description": "",
 "created_at": "Tue Jan 11 10:57:28 UTC 2011",
 "updated_at": "Tue Jan 11 11:08:03 UTC 2011",
 "overview": "\u003Cp\u003EADVENTRX Pharmaceuticals is a development-stage specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary product candidates for the treatment of cancer. The Company seeks to improve the performance of existing drugs by addressing limitations associated principally with their safety and use.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       42],
      "assets/images/resized/0011/6807/116807v1-max-150x150.jpg"],
     [[176,
       50],
      "assets/images/resized/0011/6807/116807v1-max-250x250.jpg"],
     [[176,
       50],
      "assets/images/resized/0011/6807/116807v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$22.5M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/adventrx-announces-225m-capital-raise-mulls-acquisition/2011-01-07?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Adventrx announces $22.5M capital raise",
    "raised_amount": 22500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 1,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "RA Capital Management",
         "permalink": "ra-capital-management",
         "image":
          {"available_sizes":
            [[[150,
               37],
              "assets/images/resized/0008/4805/84805v2-max-150x150.png"],
             [[230,
               58],
              "assets/images/resized/0008/4805/84805v2-max-250x250.png"],
             [[230,
               58],
              "assets/images/resized/0008/4805/84805v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": null,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://finance.yahoo.com/news/ADVENTRX-Signs-Definitive-prnews-2174950244.html?x=0\u0026.v=1\u0026.pf=personal-finance\u0026mod=pf-personal-finance",
    "source_description": "ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.",
    "acquired_year": 2011,
    "acquired_month": 2,
    "acquired_day": 14,
    "company":
     {"name": "SynthRx",
      "permalink": "synthrx",
      "image": null}}],
 "offices":
  [{"description": "",
    "address1": "6725 Mesa Ridge Rd., Suite 100",
    "address2": "",
    "zip_code": "92121",
    "city": "San Diego",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        92],
       "assets/images/resized/0011/6808/116808v1-max-150x150.jpg"],
      [[250,
        154],
       "assets/images/resized/0011/6808/116808v1-max-250x250.jpg"],
      [[450,
        278],
       "assets/images/resized/0011/6808/116808v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}